Joshua E. Logan

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Joshua E. Logan, Nikayeh Mostofizadeh, Amrita Desai et al. · PubMed · 2013 · 102 citations

Medicine, Oncology, Pharmacology +17

Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma

Tobias Klatte, Nils Kroeger, Edward N. Rampersaud et al. · Cancer · 2012 · 50 citations · Full text

Medicine, Genetics, Oncology +16

Single Center Experience with Percutaneous and Laparoscopic Cryoablation of Small Renal Masses

John B. Malcolm, Tristan Berry, Michael B. Williams et al. · Journal of Endourology · 2009 · 46 citations

Medicine, Oncology, Surgery +17

Karnofsky Performance Status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma

Patrick D. Evers, Joshua E. Logan, Veronica Sills et al. · World Journal of Urology · 2013 · 35 citations

Medicine, Oncology, Surgery +12

Renal Functional Outcomes After Cryoablation of Small Renal Masses

John B. Malcolm, Joshua E. Logan, Robert Given et al. · Journal of Endourology · 2009 · 16 citations

Medicine, Nephrology, Surgery +17